Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
The permeation of epinephrine across human dentin discs was studied in vitro. Permeation was measured across dentin of two different thicknesses, with and without the presence of smear layers. Epinephrine was readily detected at the earliest measured time (10 min) and reached peak concentrations between 30 and 50 min. Epinephrine flux (concentration multiplied by the volume of the effluent per min) increased with decreasing thickness of the discs and increased significantly with the removal of the smear layer. The T 1/2 (half-time in min necessary to reach steady-state diffusion of epinephrine) decreased as dentin thickness was reduced and fell further in the absence of the smear layer. This study suggests that the permeation of epinephrine across dentin is inversely related to dentin thickness and retarded by the presence of a smear layer. Also, the topical use of 1 mg/ml epinephrine produced therapeutically useful drug concentrations, but the rate of permeation was relatively slow.
The permeation of epinephrine across human dentin discs was studied in vitro. Permeation was measured across dentin of two different thicknesses, with and without the presence of smear layers. Epinephrine was readily detected at the earliest measured time (10 min) and reached peak concentrations between 30 and 50 min. Epinephrine flux (concentration multiplied by the volume of the effluent per min) increased with decreasing thickness of the discs and increased significantly with the removal of the smear layer. The T 1/2 (half-time in min necessary to reach steady-state diffusion of epinephrine) decreased as dentin thickness was reduced and fell further in the absence of the smear layer. This study suggests that the permeation of epinephrine across dentin is inversely related to dentin thickness and retarded by the presence of a smear layer. Also, the topical use of 1 mg/ml epinephrine produced therapeutically useful drug concentrations, but the rate of permeation was relatively slow.
In the 70 years since progesterone (P) was identified in corpus luteum extracts, its metabolism has been examined extensively in many tissues and cell lines from numerous species. In addition to the reproductive tissues and adrenals, every other tissue that has been investigated appears to have one or more P-metabolizing enzyme, each of which is specific for a particular site on the P molecule. In the past, the actions of the P metabolizing enzymes generally have been equated to a means of reducing the P concentration in the tissue microenvironment, and the products have been dismissed as inactive waste metabolites. In human breast tissues and cell lines, the following P-metabolizing enzymes have been identified: 5a-reductase, 3a-hydroxysteroid oxidoreductase (3a-HSO), 3b-HSO, 20a-HSO, and 6a-hydroxylase. Rather than providing diverse pathways for inactivating and controlling the concentration of P in breast tissue microenvironments, it is proposed that the enzymes act directly on P to produce two types of autocrines/paracrines with opposing regulatory roles in breast cancer. Evidence is reviewed which shows that P is directly converted to the 4-pregnenes, 3a-hydroxy-4-pregnen-20-one (3a-dihydroprogesterone; 3aHP) and 20a-dihydro-progesterone (20aHP), by the actions of 3a-HSO and 20a-HSO respectively and to the 5a-pregnane, 5a-pregnane-3,20-dione(5a-dihydroprogesterone; 5aP), by the irreversible action of 5a-reductase. In vitro studies on a number of breast cell lines indicate that 3aHP promotes normalcy by downregulating cell proliferation and detachment, whereas 5aP promotes mitogenesis and metastasis by stimulating cell proliferation and detachment. The hormones bind to novel, separate, and specific plasma membrane-based receptors and influence opposing actions on mitosis, apoptosis, and cytoskeletal and adhesion plaque molecules via cell signaling pathways. In normal tissue, the ratio of 4-pregnenes:5a-pregnanes is high because of high P 3a-and 20a-HSO activities/expression and low P 5a-reductase activity/expression. In breast tumor tissue and tumorigenic cell lines, the ratio is reversed in favor of the 5a-pregnanes because of altered P-metabolizing enzyme activities/expression. The evidence suggests that the promotion of breast cancer is related to changes in in situ concentrations of cancerinhibiting and -promoting P metabolites. Current estrogen-based theories and therapies apply to only a fraction of all breast cancers; the majority (about two-thirds) of breast cancer cases are estrogeninsensitive and have lacked endocrine explanations. As the P metabolites, 5aP and 3aHP, have been shown to act with equal efficacy on all breast cell lines tested, regardless of their tumorigenicity, estrogen sensitivity, and estrogen receptor/progesterone receptor status, it is proposed that they offer a new hormonal basis for all forms of breast cancer. New diagnostic and therapeutic possibilities for breast cancer progression, control, regression, and prevention are suggested.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
334 Leonard St
Brooklyn, NY 11211
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.